19-28z CAR T cells: Phase II resumed

Juno said that FDA lifted a clinical hold on the open-label, U.S. Phase II ROCKET trial evaluating IV JCAR015. FDA placed

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE